RAC 0.98% $1.51 race oncology ltd

RAC - Charts & Price Action, page-18535

  1. 95 Posts.
    lightbulb Created with Sketch. 91
    I'm asserting myself as an astute, rather than misguided investor with RAC and continue to add to my position. When I originally invested some years ago, I dreamed of membership in the 'lambo club', now I'm in it and working towards my second 'lambo'. Our CEO has assured us RAC is working hard on all deliverables: This year RC220 will be delivered and we will dose our first patient, groundbreaking / confirmational / clear marketable clinical data on RC220's CPACS and m6A RNA effects will follow thereafter, validating the opportunity outlined within the Triangle report.

    A little more patience required and I'm DCAing in this SP lull, much like how our CEO is via the personal choice for options (ex. at $4.25) instead of cash for salary.

    Note: I have refrained from using banned terms, AIMO, GLTAH.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.